Company / Depreciation & Amortization
Praxis Precision Medicines, Inc. Depreciation & Amortization History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$419.0K
FY2022
5-year range
$182.0K / $419.0K
FY2019-FY2022
Trend
+130.2%
vs FY2021
Sector context
#140 of 168
Health Care
What the data says
Praxis Precision Medicines, Inc.'s depreciation & amortization of $419,000 is lower than 83% of companies in the Health Care sector (FY2022). Depreciation & Amortization has increased for 3 consecutive years, from $37,000 in FY2019 to $419,000 in FY2022.
Based on SEC 10-K filings.
$419,000 in FY2022 with a 3-year CAGR of +124.6%.
Increased from $50,000 to $419,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +124.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.8% below sector average
Key checks
Key Insights
- Praxis Precision Medicines, Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 3-year CAGR of +124.6%, indicating consistent growth.
- In FY2022, depreciation & amortization increased 130.2% year-over-year.
- Ranks #140 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $419.0K | +130.2% |
| FY2021 | $182.0K | +264.0% |
| FY2020 | $50.0K | +35.1% |
| FY2019 | $37.0K | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026